Close Menu

Considering that there are now 4,000 to 5,000 tests for heritable conditions, the question of how good is any test if it doesn't lead to actionable results is on the mind of a lot of people in the consumer genetic testing industry. Scripps' Eric Topol is conducting an experiment to see if taking a test (in this case, they're using Navigenics) will spur people to actually improve their lifestyles. Most experts still urge caution. If you're not taking the test under genetic counseling supervision, you might as well skip it, says one.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.